Adoption of Extended-Release Buprenorphine Monthly Injections for Opioid Use Disorder

Under the mentorship of the CHERISH Dissemination & Policy Core Director Zachary Meisel and former pilot grant recipient Austin Kilaru, Ravi Gupta further examined the potential of extended-release buprenorphine and how racial disparities influence treatment adherence for people with opioid use disorder.

Ravi Gupta is an internal medicine physician and National Clinician Scholars Program fellow at the University of Pennsylvania. His research focuses on evaluating policies on the use of prescription drugs and has been published in several high-impact journals. Notably, his investigation into rising naloxone prices led to congressional investigations of companies that manufacture naloxone. He received his undergraduate degree from Ohio State University, graduated from Yale School of Medicine, completed his clinical residency at Johns Hopkins Hospital in the Urban Health track, and practices medicine at the Corporal Michael J. Crescenz VA Medical Center.